// App-Quantinova.ai

e19028 : Incidence and risk factors for ibrutinib associated atrial fibrillation.

Researchers

Presenter

  • Josephine Ngozi Emole

Principal Investigators

  • Federico Viganego

  • Matthew B. Schabath

  • Bijal D. Shah

  • Julio C. Chavez

  • Christine Marie Walko

  • Howard L. McLeod

  • Javier Pinilla-Ibarz

  • Michael G. Fradley

Medical Centers

  • H. Lee Moffitt Cancer Center & Research Institute, Riverview, FL

  • Division of Cardiovascular Medicine, University of South Florida and H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

  • Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

  • Moffitt Cancer Center, Tampa, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Arrhythmia

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Ibrutinib

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved